OR WAIT null SECS
April 15, 2023
Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.
The complexity of the RNA production process creates challenges.
April 14, 2023
FDA has granted fast track designation to Caribou Biosciences for its allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma.
April 03, 2023
Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.
Impurities and batch-to-batch variability present the biggest challenges.
March 27, 2023
PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects.
March 24, 2023
Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.
March 21, 2023
BioNTech will receive an exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 mAb candidate for solid tumor indications.
March 17, 2023
Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.
The collaboration between Genuv and Celltrion will utilize Genuv's proprietary mouse platform for antibody discovery.